Associations between actigraphy-measured sleep duration, continuity, and timing with mortality in the UK Biobank

Abstract Study Objectives To examine the associations between sleep duration, continuity, timing, and mortality using actigraphy among adults. Methods Data were from a cohort of 88 282 adults (40–69 years) in UK Biobank that wore a wrist-worn triaxial accelerometer for 7 days. Actigraphy data were p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sleep (New York, N.Y.) N.Y.), 2024-03, Vol.47 (3), p.1
Hauptverfasser: Saint-Maurice, Pedro F, Freeman, Joshua R, Russ, Daniel, Almeida, Jonas S, Shams-White, Marissa M, Patel, Shreya, Wolff-Hughes, Dana L, Watts, Eleanor L, Loftfield, Erikka, Hong, Hyokyoung G, Moore, Steven C, Matthews, Charles E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 1
container_title Sleep (New York, N.Y.)
container_volume 47
creator Saint-Maurice, Pedro F
Freeman, Joshua R
Russ, Daniel
Almeida, Jonas S
Shams-White, Marissa M
Patel, Shreya
Wolff-Hughes, Dana L
Watts, Eleanor L
Loftfield, Erikka
Hong, Hyokyoung G
Moore, Steven C
Matthews, Charles E
description Abstract Study Objectives To examine the associations between sleep duration, continuity, timing, and mortality using actigraphy among adults. Methods Data were from a cohort of 88 282 adults (40–69 years) in UK Biobank that wore a wrist-worn triaxial accelerometer for 7 days. Actigraphy data were processed to generate estimates of sleep duration and other sleep characteristics including wake after sleep onset (WASO), number of 5-minute awakenings, and midpoint for sleep onset/wake-up and the least active 5 hours (L5). Data were linked to mortality outcomes with follow-up to October 31, 2021. We implemented Cox models (hazard ratio, confidence intervals [HR, 95% CI]) to quantify sleep associations with mortality. Models were adjusted for demographics, lifestyle factors, and medical conditions. Results Over an average of 6.8 years 2973 deaths occurred (1700 cancer, 586 CVD deaths). Overall sleep duration was significantly associated with risk for all-cause (p 
doi_str_mv 10.1093/sleep/zsad312
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10925955</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A787679585</galeid><oup_id>10.1093/sleep/zsad312</oup_id><sourcerecordid>A787679585</sourcerecordid><originalsourceid>FETCH-LOGICAL-c516t-85c2e5f51c3342a3818c35d711027f100c18a4051d034909e87dd8874d6158723</originalsourceid><addsrcrecordid>eNqFks9vFCEUx4nR2LV69GpIvHjotDAMM3Aya-Ov2MSLPRMW3uxSZ2AEps3618tu19YaE8OBwPu878v3vYfQS0pOKZHsLA0A09nPpC2j9SO0oJyTSpbQY7QgtKWVoIQfoWcpXZHybiR7io6YIG3bSrZA0zKlYJzOLviEV5BvADzWJrt11NNmW42g0xzB4n0hbOe4Z0-wCT47P7u8PcHaW5zd6Pwa37i8wWOIWQ8lhJ3HeQP48gt-58JK--_P0ZNeDwleHO5jdPnh_bfzT9XF14-fz5cXleG0zZXgpgbec2oYa2rNBBWGcdtRSuqup4QYKnRDOLWENZJIEJ21QnSNbSkXXc2O0dtb3WlejWAN-Bz1oKboRh23KminHka826h1uFaldTWXnBeFNweFGH7MkLIaXTIwDNpDmJOqJallw9o9-vov9CrM0Rd_qkxFENoVA_fUWg-gnO9DKWx2omrZia7tJBc7rdN_UOVYGF1pOvSu_D9IqG4TTAwpRejvTFKyc8PUfnTqsCOFf_VnZ-7o30txbzzM03-0fgFPOcaz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3128017381</pqid></control><display><type>article</type><title>Associations between actigraphy-measured sleep duration, continuity, and timing with mortality in the UK Biobank</title><source>Oxford University Press Journals</source><source>MEDLINE</source><source>Free E-Journal (出版社公開部分のみ)</source><source>Alma/SFX Local Collection</source><creator>Saint-Maurice, Pedro F ; Freeman, Joshua R ; Russ, Daniel ; Almeida, Jonas S ; Shams-White, Marissa M ; Patel, Shreya ; Wolff-Hughes, Dana L ; Watts, Eleanor L ; Loftfield, Erikka ; Hong, Hyokyoung G ; Moore, Steven C ; Matthews, Charles E</creator><creatorcontrib>Saint-Maurice, Pedro F ; Freeman, Joshua R ; Russ, Daniel ; Almeida, Jonas S ; Shams-White, Marissa M ; Patel, Shreya ; Wolff-Hughes, Dana L ; Watts, Eleanor L ; Loftfield, Erikka ; Hong, Hyokyoung G ; Moore, Steven C ; Matthews, Charles E</creatorcontrib><description>Abstract Study Objectives To examine the associations between sleep duration, continuity, timing, and mortality using actigraphy among adults. Methods Data were from a cohort of 88 282 adults (40–69 years) in UK Biobank that wore a wrist-worn triaxial accelerometer for 7 days. Actigraphy data were processed to generate estimates of sleep duration and other sleep characteristics including wake after sleep onset (WASO), number of 5-minute awakenings, and midpoint for sleep onset/wake-up and the least active 5 hours (L5). Data were linked to mortality outcomes with follow-up to October 31, 2021. We implemented Cox models (hazard ratio, confidence intervals [HR, 95% CI]) to quantify sleep associations with mortality. Models were adjusted for demographics, lifestyle factors, and medical conditions. Results Over an average of 6.8 years 2973 deaths occurred (1700 cancer, 586 CVD deaths). Overall sleep duration was significantly associated with risk for all-cause (p &lt; 0.01), cancer (p &lt; 0.01), and CVD (p = 0.03) mortality. For example, when compared to sleep durations of 7.0 hrs/d, durations of 5 hrs/d were associated with a 29% higher risk for all-cause mortality (HR: 1.29 [1.09, 1.52]). WASO and number of awakenings were not associated with mortality. Individuals with L5 early or late midpoints (&lt;2:30 or ≥ 3:30) had a ~20% higher risk for all-cause mortality, compared to those with intermediate L5 midpoints (3:00–3:29; p ≤ 0.01; e.g. HR ≥ 3:30: 1.19 [1.07, 1.32]). Conclusions Shorter sleep duration and both early and late sleep timing were associated with a higher mortality risk. These findings reinforce the importance of public health efforts to promote healthy sleep patterns in adults. Graphical Abstract Graphical Abstract</description><identifier>ISSN: 0161-8105</identifier><identifier>ISSN: 1550-9109</identifier><identifier>EISSN: 1550-9109</identifier><identifier>DOI: 10.1093/sleep/zsad312</identifier><identifier>PMID: 38066693</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Actigraphy ; Adult ; Analysis ; Biobanks ; Biological Specimen Banks ; Cardiovascular Diseases ; Epidemiology ; Health aspects ; Humans ; Mortality ; Neoplasms ; Sleep ; Sleep Duration ; Sleep, Health, and Disease ; UK Biobank ; United Kingdom</subject><ispartof>Sleep (New York, N.Y.), 2024-03, Vol.47 (3), p.1</ispartof><rights>Published by Oxford University Press on behalf of Sleep Research Society (SRS) 2023. 2023</rights><rights>Published by Oxford University Press on behalf of Sleep Research Society (SRS) 2023.</rights><rights>COPYRIGHT 2024 Oxford University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c516t-85c2e5f51c3342a3818c35d711027f100c18a4051d034909e87dd8874d6158723</citedby><cites>FETCH-LOGICAL-c516t-85c2e5f51c3342a3818c35d711027f100c18a4051d034909e87dd8874d6158723</cites><orcidid>0000-0001-8037-3103 ; 0000-0003-4040-4416 ; 0000-0002-7883-7922 ; 0000-0002-3573-8748 ; 0000-0001-7483-7848 ; 0000-0002-8169-1661</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38066693$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saint-Maurice, Pedro F</creatorcontrib><creatorcontrib>Freeman, Joshua R</creatorcontrib><creatorcontrib>Russ, Daniel</creatorcontrib><creatorcontrib>Almeida, Jonas S</creatorcontrib><creatorcontrib>Shams-White, Marissa M</creatorcontrib><creatorcontrib>Patel, Shreya</creatorcontrib><creatorcontrib>Wolff-Hughes, Dana L</creatorcontrib><creatorcontrib>Watts, Eleanor L</creatorcontrib><creatorcontrib>Loftfield, Erikka</creatorcontrib><creatorcontrib>Hong, Hyokyoung G</creatorcontrib><creatorcontrib>Moore, Steven C</creatorcontrib><creatorcontrib>Matthews, Charles E</creatorcontrib><title>Associations between actigraphy-measured sleep duration, continuity, and timing with mortality in the UK Biobank</title><title>Sleep (New York, N.Y.)</title><addtitle>Sleep</addtitle><description>Abstract Study Objectives To examine the associations between sleep duration, continuity, timing, and mortality using actigraphy among adults. Methods Data were from a cohort of 88 282 adults (40–69 years) in UK Biobank that wore a wrist-worn triaxial accelerometer for 7 days. Actigraphy data were processed to generate estimates of sleep duration and other sleep characteristics including wake after sleep onset (WASO), number of 5-minute awakenings, and midpoint for sleep onset/wake-up and the least active 5 hours (L5). Data were linked to mortality outcomes with follow-up to October 31, 2021. We implemented Cox models (hazard ratio, confidence intervals [HR, 95% CI]) to quantify sleep associations with mortality. Models were adjusted for demographics, lifestyle factors, and medical conditions. Results Over an average of 6.8 years 2973 deaths occurred (1700 cancer, 586 CVD deaths). Overall sleep duration was significantly associated with risk for all-cause (p &lt; 0.01), cancer (p &lt; 0.01), and CVD (p = 0.03) mortality. For example, when compared to sleep durations of 7.0 hrs/d, durations of 5 hrs/d were associated with a 29% higher risk for all-cause mortality (HR: 1.29 [1.09, 1.52]). WASO and number of awakenings were not associated with mortality. Individuals with L5 early or late midpoints (&lt;2:30 or ≥ 3:30) had a ~20% higher risk for all-cause mortality, compared to those with intermediate L5 midpoints (3:00–3:29; p ≤ 0.01; e.g. HR ≥ 3:30: 1.19 [1.07, 1.32]). Conclusions Shorter sleep duration and both early and late sleep timing were associated with a higher mortality risk. These findings reinforce the importance of public health efforts to promote healthy sleep patterns in adults. Graphical Abstract Graphical Abstract</description><subject>Actigraphy</subject><subject>Adult</subject><subject>Analysis</subject><subject>Biobanks</subject><subject>Biological Specimen Banks</subject><subject>Cardiovascular Diseases</subject><subject>Epidemiology</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Mortality</subject><subject>Neoplasms</subject><subject>Sleep</subject><subject>Sleep Duration</subject><subject>Sleep, Health, and Disease</subject><subject>UK Biobank</subject><subject>United Kingdom</subject><issn>0161-8105</issn><issn>1550-9109</issn><issn>1550-9109</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFks9vFCEUx4nR2LV69GpIvHjotDAMM3Aya-Ov2MSLPRMW3uxSZ2AEps3618tu19YaE8OBwPu878v3vYfQS0pOKZHsLA0A09nPpC2j9SO0oJyTSpbQY7QgtKWVoIQfoWcpXZHybiR7io6YIG3bSrZA0zKlYJzOLviEV5BvADzWJrt11NNmW42g0xzB4n0hbOe4Z0-wCT47P7u8PcHaW5zd6Pwa37i8wWOIWQ8lhJ3HeQP48gt-58JK--_P0ZNeDwleHO5jdPnh_bfzT9XF14-fz5cXleG0zZXgpgbec2oYa2rNBBWGcdtRSuqup4QYKnRDOLWENZJIEJ21QnSNbSkXXc2O0dtb3WlejWAN-Bz1oKboRh23KminHka826h1uFaldTWXnBeFNweFGH7MkLIaXTIwDNpDmJOqJallw9o9-vov9CrM0Rd_qkxFENoVA_fUWg-gnO9DKWx2omrZia7tJBc7rdN_UOVYGF1pOvSu_D9IqG4TTAwpRejvTFKyc8PUfnTqsCOFf_VnZ-7o30txbzzM03-0fgFPOcaz</recordid><startdate>20240311</startdate><enddate>20240311</enddate><creator>Saint-Maurice, Pedro F</creator><creator>Freeman, Joshua R</creator><creator>Russ, Daniel</creator><creator>Almeida, Jonas S</creator><creator>Shams-White, Marissa M</creator><creator>Patel, Shreya</creator><creator>Wolff-Hughes, Dana L</creator><creator>Watts, Eleanor L</creator><creator>Loftfield, Erikka</creator><creator>Hong, Hyokyoung G</creator><creator>Moore, Steven C</creator><creator>Matthews, Charles E</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8037-3103</orcidid><orcidid>https://orcid.org/0000-0003-4040-4416</orcidid><orcidid>https://orcid.org/0000-0002-7883-7922</orcidid><orcidid>https://orcid.org/0000-0002-3573-8748</orcidid><orcidid>https://orcid.org/0000-0001-7483-7848</orcidid><orcidid>https://orcid.org/0000-0002-8169-1661</orcidid></search><sort><creationdate>20240311</creationdate><title>Associations between actigraphy-measured sleep duration, continuity, and timing with mortality in the UK Biobank</title><author>Saint-Maurice, Pedro F ; Freeman, Joshua R ; Russ, Daniel ; Almeida, Jonas S ; Shams-White, Marissa M ; Patel, Shreya ; Wolff-Hughes, Dana L ; Watts, Eleanor L ; Loftfield, Erikka ; Hong, Hyokyoung G ; Moore, Steven C ; Matthews, Charles E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c516t-85c2e5f51c3342a3818c35d711027f100c18a4051d034909e87dd8874d6158723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Actigraphy</topic><topic>Adult</topic><topic>Analysis</topic><topic>Biobanks</topic><topic>Biological Specimen Banks</topic><topic>Cardiovascular Diseases</topic><topic>Epidemiology</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Mortality</topic><topic>Neoplasms</topic><topic>Sleep</topic><topic>Sleep Duration</topic><topic>Sleep, Health, and Disease</topic><topic>UK Biobank</topic><topic>United Kingdom</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saint-Maurice, Pedro F</creatorcontrib><creatorcontrib>Freeman, Joshua R</creatorcontrib><creatorcontrib>Russ, Daniel</creatorcontrib><creatorcontrib>Almeida, Jonas S</creatorcontrib><creatorcontrib>Shams-White, Marissa M</creatorcontrib><creatorcontrib>Patel, Shreya</creatorcontrib><creatorcontrib>Wolff-Hughes, Dana L</creatorcontrib><creatorcontrib>Watts, Eleanor L</creatorcontrib><creatorcontrib>Loftfield, Erikka</creatorcontrib><creatorcontrib>Hong, Hyokyoung G</creatorcontrib><creatorcontrib>Moore, Steven C</creatorcontrib><creatorcontrib>Matthews, Charles E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Sleep (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saint-Maurice, Pedro F</au><au>Freeman, Joshua R</au><au>Russ, Daniel</au><au>Almeida, Jonas S</au><au>Shams-White, Marissa M</au><au>Patel, Shreya</au><au>Wolff-Hughes, Dana L</au><au>Watts, Eleanor L</au><au>Loftfield, Erikka</au><au>Hong, Hyokyoung G</au><au>Moore, Steven C</au><au>Matthews, Charles E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Associations between actigraphy-measured sleep duration, continuity, and timing with mortality in the UK Biobank</atitle><jtitle>Sleep (New York, N.Y.)</jtitle><addtitle>Sleep</addtitle><date>2024-03-11</date><risdate>2024</risdate><volume>47</volume><issue>3</issue><spage>1</spage><pages>1-</pages><issn>0161-8105</issn><issn>1550-9109</issn><eissn>1550-9109</eissn><abstract>Abstract Study Objectives To examine the associations between sleep duration, continuity, timing, and mortality using actigraphy among adults. Methods Data were from a cohort of 88 282 adults (40–69 years) in UK Biobank that wore a wrist-worn triaxial accelerometer for 7 days. Actigraphy data were processed to generate estimates of sleep duration and other sleep characteristics including wake after sleep onset (WASO), number of 5-minute awakenings, and midpoint for sleep onset/wake-up and the least active 5 hours (L5). Data were linked to mortality outcomes with follow-up to October 31, 2021. We implemented Cox models (hazard ratio, confidence intervals [HR, 95% CI]) to quantify sleep associations with mortality. Models were adjusted for demographics, lifestyle factors, and medical conditions. Results Over an average of 6.8 years 2973 deaths occurred (1700 cancer, 586 CVD deaths). Overall sleep duration was significantly associated with risk for all-cause (p &lt; 0.01), cancer (p &lt; 0.01), and CVD (p = 0.03) mortality. For example, when compared to sleep durations of 7.0 hrs/d, durations of 5 hrs/d were associated with a 29% higher risk for all-cause mortality (HR: 1.29 [1.09, 1.52]). WASO and number of awakenings were not associated with mortality. Individuals with L5 early or late midpoints (&lt;2:30 or ≥ 3:30) had a ~20% higher risk for all-cause mortality, compared to those with intermediate L5 midpoints (3:00–3:29; p ≤ 0.01; e.g. HR ≥ 3:30: 1.19 [1.07, 1.32]). Conclusions Shorter sleep duration and both early and late sleep timing were associated with a higher mortality risk. These findings reinforce the importance of public health efforts to promote healthy sleep patterns in adults. Graphical Abstract Graphical Abstract</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>38066693</pmid><doi>10.1093/sleep/zsad312</doi><orcidid>https://orcid.org/0000-0001-8037-3103</orcidid><orcidid>https://orcid.org/0000-0003-4040-4416</orcidid><orcidid>https://orcid.org/0000-0002-7883-7922</orcidid><orcidid>https://orcid.org/0000-0002-3573-8748</orcidid><orcidid>https://orcid.org/0000-0001-7483-7848</orcidid><orcidid>https://orcid.org/0000-0002-8169-1661</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0161-8105
ispartof Sleep (New York, N.Y.), 2024-03, Vol.47 (3), p.1
issn 0161-8105
1550-9109
1550-9109
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10925955
source Oxford University Press Journals; MEDLINE; Free E-Journal (出版社公開部分のみ); Alma/SFX Local Collection
subjects Actigraphy
Adult
Analysis
Biobanks
Biological Specimen Banks
Cardiovascular Diseases
Epidemiology
Health aspects
Humans
Mortality
Neoplasms
Sleep
Sleep Duration
Sleep, Health, and Disease
UK Biobank
United Kingdom
title Associations between actigraphy-measured sleep duration, continuity, and timing with mortality in the UK Biobank
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T10%3A50%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Associations%20between%20actigraphy-measured%20sleep%20duration,%20continuity,%20and%20timing%20with%20mortality%20in%20the%20UK%20Biobank&rft.jtitle=Sleep%20(New%20York,%20N.Y.)&rft.au=Saint-Maurice,%20Pedro%20F&rft.date=2024-03-11&rft.volume=47&rft.issue=3&rft.spage=1&rft.pages=1-&rft.issn=0161-8105&rft.eissn=1550-9109&rft_id=info:doi/10.1093/sleep/zsad312&rft_dat=%3Cgale_pubme%3EA787679585%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3128017381&rft_id=info:pmid/38066693&rft_galeid=A787679585&rft_oup_id=10.1093/sleep/zsad312&rfr_iscdi=true